Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Farmacosmo S.p.A. is a company operating in the healthcare and wellness sector, focused specifically on the online retailing of pharmaceutical and personal care products. Its primary function is to bridge the gap between consumers and a wide range of health-related products through a seamless digital platform. Notably, Farmacosmo S.p.A. offers an extensive catalog of items, including over-the-counter medications, dietary supplements, beauty products, and medical devices, catering to diverse consumer needs. With the increasing shift towards e-commerce and digital health solutions, Farmacosmo plays a significant role, facilitating easy and convenient access to healthcare products. The company impacts the pharmaceutical, personal care, and retail industries, and its operations underscore the growing trend of digital transformations within traditional healthcare sectors. As an active player in driving the digitization of health and wellness services, Farmacosmo S.p.A. is instrumental in shaping consumer behaviors towards online health purchases, amplifying its significance in the broader market landscape.
The business is unprofitable at the operating level (-9.83% margin). The thesis depends entirely on whether and when it reaches sustainable profitability.
Revenue declined 12.2% YoY. Margins deteriorated 6.6pp alongside, both lines moving the wrong way.
ROIC dropped from -9.69% to -27.88%, capital efficiency is deteriorating. Negative free cash flow of -€2M. The business is consuming cash, not generating it.
Profitability & Returns
Revenue (TTM)
€56M
▼ -12.2% YoY
Net Income (TTM)
-€5M
▼ -50.0% YoY
Op. Margin
-9.83%
▼ -6.6pp YoY
ROIC
-27.88%
▼ -18.2pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
-€2M
▲ +35.6% YoY
Op. Cash Flow (TTM)
-€2M
▼ -20.9% YoY
Net Debt
€7M
Cash & Equiv.
€947K
3Y CAGR: -5.4%
Continue Research